Skip to main content

Matilde Lleonart Pajarin

Institutions of which they are part

Head of group
Biomedical Research in Cancer Stem Cells
Vall Hebron Institut de Recerca

Matilde Lleonart Pajarin

Institutions of which they are part

Head of group
Biomedical Research in Cancer Stem Cells
Vall Hebron Institut de Recerca

Projects

Estudi de la resistència a fàrmacs en carcinoma de cèl·lules escamoses de cap i coll (HNSCC)

IP: Matilde Lleonart Pajarin
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 90983.33
Reference: IFI18/00046
Duration: 01/01/2019 - 20/09/2023

Biomedical Research in Cancer Stem Cells

IP: Matilde Lleonart Pajarin
Collaborators: -
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2017SGR01121
Duration: 01/01/2017 - 31/12/2020

GC16173720CARR Definición de mecanismos clave de la multiresistencia de tumores de cabeza y cuello a los tratamientos quimio- y radioterapéuticos. Identificación de nuevos antitumorales individualizados.

IP: Matilde Lleonart Pajarin
Collaborators: Yoelsis Garcia Mayea, Juan Lorente Guerrero, Josep Castellví Vives, Vicente Peg Camara, Almudena Sanchez Garcia
Funding agency: Asociación Española Contra el Cáncer
Funding: 380000
Reference: AECC/GCE/2016/LLEONART
Duration: 01/10/2016 - 30/09/2022

Nuevas terapias aplicables a cánceres mamarios de naturaleza agresiva y metastática en base a aniquilar la población de células madre de cáncer.

IP: Matilde Lleonart Pajarin
Collaborators: Margarita Alberola Ferranti, Carmela Iglesias i Felip, Josep Castellví Vives
Funding agency: Instituto de Salud Carlos III
Funding: 195415
Reference: PI15/01262
Duration: 01/01/2016 - 30/11/2020

Related news

On World Cancer Research Day, we highlight the oncology research model of the Vall d'Hebron Campus that allows laboratory results to be transferred as quickly as possible to clinical practice.

Vall d’Hebron ha celebrat avui la Jornada del Dia Mundial contra el Càncer, una malaltia cada cop més freqüent que patiran al llarg de la vida un de cada dos homes i una de cada tres dones del nostre entorn.

The work has compared sensitive and resistant cells to cisplatin treatment to understand the mechanisms involved in resistance and to find new biomarkers and therapies.

Related professionals

Immaculada Creus Gonzalez

Immaculada Creus Gonzalez

Research technician
Read more
Marta Miarons Font

Marta Miarons Font

Head of group
Basic, Translational and Clinical Pharmacy Research
Read more
Alvaro Garcia Tornel Garcia Camba

Alvaro Garcia Tornel Garcia Camba

Senior researcher
Stroke research
Read more
Ferran Polo Torres

Ferran Polo Torres

Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.